US doctors and teaching hospitals got $6.49 billion from drug and medical-device makers in 2014, according to new government data .

US doctors and teaching hospitals got $6.49 billion from drug and medical-device makers in 2014, according to new government data on the financial lin(...)

Dr Dorota Wencel, Dublin City University, and Kerry Naughton of BlueBridge Technologies: their project will focus on the development of a critical care monitor for vulnerable patients

The Science Foundation Ireland (SFI) Industry Research Fellowship programme offers post-graduate researchers in higher education institutions around I(...)

A robotic arm works above a tray of samples at an AstraZenenca Plc facility Photograph: NewsCast/AstraZeneca Plc via Bloomberg

AstraZeneca’s hopes of topping $45 billion in revenue by 2023 have been dealt a blow by a problem with an experimental psoriasis drug that the drugmak(...)

CRH closed up 2.8 per cent at €26.55, following the announcement that regulators had cleared its planned €6.5bn purchase of assets from Holcim and Lafarge. (Photograph: Brenda Fitzsimons)

World stocks hit all-time highs on Friday as corporate updates in Europe and a post- dot.com-boom peak for the US Nasdaq stoked investor optimism. Eur(...)

ECB chief Mario Draghi said quantitative easing will continue until there’s sustained improvement in inflation. Photograph: Thierry Charlier/AFP/Getty Images

The Iseq in Dublin advanced by 1 per cent yesterday while UK stocks climbed to a 2008 high. The FTSE 100 in London added 0.3 per cent, as did the bro(...)

Traders work at the post that trades FedEx on the floor of the New York Stock Exchange Photograph:  Brendan McDermid/Reuters

European shares hit a 14-year high on Wednesday before a meeting at which the European Central Bank is expected to affirm its loose policy stance, a(...)

AstraZeneca may have a second chronic obstructive pulmonary disease treatmentan after a study showed an experimental combination of lung drugs improved breathing function. Photograph: Jason Alden/Bloomberg

AstraZeneca said an experimental combination of lung drugs improved breathing function, potentially giving the UK firm its second chronic obstructive (...)

Analysts warned that now that the European Central Bank had decided to use its veto on Greek bonds, a solution to the country’s debt crisis had to be found quickly.

A fall in Greek shares, sparked by the European Central Bank’s decision to stop accepting the country’s bonds, held back stock markets yesterday. A(...)

Bottles of AstraZeneca’s Nexium heartburn medication. Photographer: Daniel Acker/Bloomberg

AstraZeneca, the second-largest UK drug maker, said fourth-quarter earnings fell 33 per cent as revenue declined for two of its best-selling drugs and(...)

Pfizer has offered $90 per share in cash for Hospira Photograph: Reuters

Pharmaceutical giant Pfizer has offered to buy Hospira for about $15 billion (€13bn) to boost its portfolio of generic injectible drugs and biosimilar(...)